Literature DB >> 35867206

Dysregulated miRNAs in Progression and Pathogenesis of Alzheimer's Disease.

Tania Arora1, Vikash Prashar1, Randeep Singh1, Tushar Singh Barwal1, Harish Changotra2, Arti Sharma3, Jyoti Parkash4.   

Abstract

Alzheimer's disease (AD) is a progressive degeneration of neurons due to the accumulation of amyloid-β peptide (Aβ) and hyper-phosphorylation of tau protein in the neuronal milieu leading to increased oxidative stress and apoptosis. Numerous factors contribute towards the progression of AD, including miRNA, which are 22-24 nucleotides long sequence which acts as critical regulators of cellular processes by binding to 3' UTR of mRNA, regulating its expression post-transcriptionally. This review aims to determine the miRNA with the most significant dysregulation in the brain and cerebrospinal fluid (CSF) of human patients. A systemized inclusion/exclusion criterion has been utilized based on selected keywords followed by screening of those articles to conclude a list of 8 highly dysregulated miRNAs based on the fold change of AD vs control patients, which could be used in clinical testing as these miRNAs play central role in the pathophysiology of AD. Furthermore, a network study of highly dysregulated miRNA estimated the association of these miRNA in the mediation of Aβ generation and aggregation, inhibition of autophagy, reduction of Aβ clearance, microglial and astrocytic activation, neuro-inflammation, tau hyper-phosphorylation, and synaptic loss.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Alzheimer’s disease; Brain; Cerebrospinal fluid; Dysregulation; Network study; miRNA

Mesh:

Substances:

Year:  2022        PMID: 35867206     DOI: 10.1007/s12035-022-02950-z

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.682


  60 in total

1.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

Review 2.  Proteolytic processing of Alzheimer's β-amyloid precursor protein.

Authors:  Han Zhang; Qilin Ma; Yun-Wu Zhang; Huaxi Xu
Journal:  J Neurochem       Date:  2011-11-28       Impact factor: 5.372

Review 3.  Are certain lifestyle habits associated with lower Alzheimer's disease risk?

Authors:  Lana Arab; Marwan N Sabbagh
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 4.  The role of apolipoprotein E in Alzheimer's disease.

Authors:  Jungsu Kim; Jacob M Basak; David M Holtzman
Journal:  Neuron       Date:  2009-08-13       Impact factor: 17.173

Review 5.  Environmental risk factors for dementia: a systematic review.

Authors:  Lewis O J Killin; John M Starr; Ivy J Shiue; Tom C Russ
Journal:  BMC Geriatr       Date:  2016-10-12       Impact factor: 3.921

6.  Neurofibrillary tangles in Alzheimer's disease: elucidation of the molecular mechanism by immunohistochemistry and tau protein phospho-proteomics.

Authors:  Athanasios Metaxas; Stefan J Kempf
Journal:  Neural Regen Res       Date:  2016-10       Impact factor: 5.135

7.  Editorial: Memory Processes in Medial Temporal Lobe: Experimental, Theoretical and Computational Approaches.

Authors:  Vassilis Cutsuridis; Motoharu Yoshida
Journal:  Front Syst Neurosci       Date:  2017-04-06

Review 8.  Synaptic Elimination in Neurological Disorders.

Authors:  Pablo L Cardozo; Izabella B Q de Lima; Esther M A Maciel; Nathália C Silva; Tomas Dobransky; Fabíola M Ribeiro
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

Review 9.  Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies.

Authors:  Dapinder Kaur; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Simona Bungau
Journal:  Neurochem Res       Date:  2021-08-06       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.